Literature DB >> 19435295

Design, synthesis, and biological evaluation of conformationally constrained cis-amide Hsp90 inhibitors.

Adam S Duerfeldt1, Gary E L Brandt, Brian S J Blagg.   

Abstract

Conformationally constrained cis-amide chimeric inhibitors of Hsp90 have been synthesized and evaluated for their Hsp90 inhibitory activity. These new compounds exhibited Hsp90 ATPase inhibition and induced Hsp90-dependent client protein degradation in a dose-dependent manner. Biological data reported herein suggests that amide bond isomerization of geldanamycin derivatives plays an important role in affinity for the heteroprotein complex present in cancer cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19435295      PMCID: PMC2697668          DOI: 10.1021/ol900783m

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  27 in total

1.  Heat shock protein-chaperoned peptides but not free peptides introduced into the cytosol are presented efficiently by major histocompatibility complex I molecules.

Authors:  R J Binder; N E Blachere; P K Srivastava
Journal:  J Biol Chem       Date:  2001-03-08       Impact factor: 5.157

Review 2.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

3.  Coordinated ATP hydrolysis by the Hsp90 dimer.

Authors:  K Richter; P Muschler; O Hainzl; J Buchner
Journal:  J Biol Chem       Date:  2001-07-05       Impact factor: 5.157

Review 4.  Molecular chaperones--cellular machines for protein folding.

Authors:  Stefan Walter; Johannes Buchner
Journal:  Angew Chem Int Ed Engl       Date:  2002-04-02       Impact factor: 15.336

5.  Optimizing natural products by biosynthetic engineering: discovery of nonquinone Hsp90 inhibitors.

Authors:  Ming-Qiang Zhang; Sabine Gaisser; Mohammad Nur-E-Alam; Lesley S Sheehan; William A Vousden; Nikolaos Gaitatzis; Gerrard Peck; Nigel J Coates; Steven J Moss; Markus Radzom; Teresa A Foster; Rose M Sheridan; Matthew A Gregory; S Mark Roe; Chrisostomos Prodromou; Laurence Pearl; Susan M Boyd; Barrie Wilkinson; Christine J Martin
Journal:  J Med Chem       Date:  2008-09-25       Impact factor: 7.446

6.  17AAG: low target binding affinity and potent cell activity--finding an explanation.

Authors:  Gabriela Chiosis; Henri Huezo; Neal Rosen; Edward Mimnaugh; Luke Whitesell; Len Neckers
Journal:  Mol Cancer Ther       Date:  2003-02       Impact factor: 6.261

Review 7.  HSP90 as a new therapeutic target for cancer therapy: the story unfolds.

Authors:  Alison Maloney; Paul Workman
Journal:  Expert Opin Biol Ther       Date:  2002-01       Impact factor: 4.388

8.  Quantum chemical calculations and mutational analysis suggest heat shock protein 90 catalyzes trans-cis isomerization of geldanamycin.

Authors:  Yong-Sok Lee; Monica G Marcu; Len Neckers
Journal:  Chem Biol       Date:  2004-07

9.  A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors.

Authors:  Adeela Kamal; Lia Thao; John Sensintaffar; Lin Zhang; Marcus F Boehm; Lawrence C Fritz; Francis J Burrows
Journal:  Nature       Date:  2003-09-25       Impact factor: 49.962

10.  Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation.

Authors:  L Whitesell; E G Mimnaugh; B De Costa; C E Myers; L M Neckers
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

View more
  9 in total

1.  A mechanistic and structural analysis of the inhibition of the 90-kDa heat shock protein by the benzoquinone and hydroquinone ansamycins.

Authors:  Philip Reigan; David Siegel; Wenchang Guo; David Ross
Journal:  Mol Pharmacol       Date:  2011-02-01       Impact factor: 4.436

2.  Scalable and chromatography-free synthesis of 2-(2-formylalkyl)arenecarboxylic acid derivatives through the supramolecularly controlled hydroformylation of vinylarene-2-carboxylic acids.

Authors:  Paweł Dydio; Joost N H Reek
Journal:  Nat Protoc       Date:  2014-04-24       Impact factor: 13.491

3.  Development of radamide analogs as Grp94 inhibitors.

Authors:  Aaron Muth; Vincent Crowley; Anuj Khandelwal; Sanket Mishra; Jinbo Zhao; Jessica Hall; Brian S J Blagg
Journal:  Bioorg Med Chem       Date:  2014-06-12       Impact factor: 3.641

4.  Pharmacological tuning of heat shock protein 70 modulates polyglutamine toxicity and aggregation.

Authors:  Sidhartha M Chafekar; Susanne Wisén; Andrea D Thompson; AnaLisa Echeverria; Gladis M Walter; Christopher G Evans; Leah N Makley; Jason E Gestwicki; Martin L Duennwald
Journal:  ACS Chem Biol       Date:  2012-06-22       Impact factor: 5.100

Review 5.  Natural Product Inspired N-Terminal Hsp90 Inhibitors: From Bench to Bedside?

Authors:  Anuj Khandelwal; Vincent M Crowley; Brian S J Blagg
Journal:  Med Res Rev       Date:  2015-05-25       Impact factor: 12.944

Review 6.  Alternate strategies of Hsp90 modulation for the treatment of cancer and other diseases.

Authors:  Gary E L Brandt; Brian S J Blagg
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

7.  Design, synthesis, and biological activity of bicyclic radester analogues as Hsp90 inhibitors.

Authors:  Vinod D Jadhav; Adam S Duerfeldt; Brian S J Blagg
Journal:  Bioorg Med Chem Lett       Date:  2009-10-25       Impact factor: 2.823

Review 8.  Proteostasis In The Endoplasmic Reticulum: Road to Cure.

Authors:  Su Min Nam; Young Joo Jeon
Journal:  Cancers (Basel)       Date:  2019-11-14       Impact factor: 6.639

9.  A domino reaction for generating β-aryl aldehydes from alkynes by substrate recognition catalysis.

Authors:  Weiwei Fang; Felix Bauer; Yaxi Dong; Bernhard Breit
Journal:  Nat Commun       Date:  2019-10-25       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.